Case Study: Top 50 Pharma accelerates FDA clinical evidence validation with Causaly

Top 50 Pharma accelerates FDA submission readiness with Causaly

The customer, a top 50 pharma company, faced a challenge where a Senior Medical Manager needed to validate clinical evidence for an FDA label update. Their existing manual workflow for cross-checking trial results with disease biology and regulatory data was slow and inefficient. They turned to Causaly to accelerate this process.

Using Causaly's Bio Graph and Agentic Research, the team rapidly confirmed the drug's mechanism of action and consolidated evidence into structured, fully-cited reports. Causaly significantly reduced the time required for validation, enabling faster FDA submission preparation. The solution replaced manual reviews with an efficient, evidence-driven workflow, strengthening the scientific rationale and improving cross-team alignment.